Cancer burden may be changing for people living with HIV

April 5, 2017, American Association for Cancer Research

The total number of cancer cases diagnosed among people living with the human immunodeficiency virus (HIV) is projected to decline in coming years, due mostly to declines in non-Hodgkin lymphoma and Kaposi sarcoma. Certain other cancers, such as prostate and lung, are expected to rise, according to data presented here at the AACR Annual Meeting 2017, April 1-5.

"The widespread use of modern antiretroviral therapies to treat HIV has decreased the risk of some cancers while at the same time dramatically increasing life expectancy," said the study's lead author, Jessica Yasmine Islam, MPH, a doctoral student at the Gillings School of Global Public Health at the University of North Carolina, Chapel Hill. "We estimated future risk and burden for the U.S. population living with HIV in order to anticipate their need for cancer prevention, early detection, and treatment," she explained.

HIV is a virus that attacks the immune system and, if left unchecked, can lead to AIDS. The use of antiretroviral drugs, which were developed in the 1990s, stalls the progression of HIV, dramatically extending the lives of many infected people.

In 2006, only about 4 percent of the total U.S. HIV population was age 65 or older. By 2030, more than 20 percent of the total U.S. HIV population is expected to be 65 or older, according to estimates from the Centers for Disease Control and Prevention (CDC). Effective HIV treatment has also decreased the risk of AIDS-defining malignancies: Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer.

Islam and colleagues from the National Cancer Institute and the CDC used cancer incidence data collected from the HIV/AIDS Cancer Match Study. They estimated cancer incidence rates in people living with HIV through 2030, assuming observed trends in incidence continue. To estimate the number of cancers projected to occur in this population in the future, the investigators multiplied the number of people expected to be living with HIV in the U.S. each year through 2030 by cancer incidence rates.

In 2010, an estimated 7,909 cases of cancer were diagnosed among people living with HIV. Of these, 2,719 were AIDS-defining cancers and 5,190 were non-AIDS-defining cancers. The overall number of cancers is projected to drop to 6,495 in 2030, with AIDS-defining cancers declining dramatically to 710 and non-AIDS-defining cancers increasing somewhat to 5,794. While Kaposi sarcoma and non-Hodgkin lymphoma were estimated to be the most common cancers in this population in 2010, by 2030, the most common cancers in this population are expected to be prostate, lung, liver, and anal cancer, the study showed.

Islam explained that several factors are expected to contribute to the shift in cancer burden. First, the that many are prescribed reduce immune suppression, thereby decreasing the risk of some cancers associated with viral infections and immune disruption, most notably Kaposi sarcoma and non-Hodgkin lymphoma. Also, the aging of the HIV-positive population will result in certain cancers occurring more frequently. For example, as more HIV-positive men reach an age where prostate cancer becomes more common, the number of cases diagnosed will rise in that population, she said.

"It is critical that we continue to monitor cancer risk in the HIV-infected ," Islam said. "Targeted cancer prevention, early detection, and control efforts are needed, including smoking cessation, treatment of hepatitis C and B viruses, age-appropriate cancer screening, and continued widespread treatment with antiretroviral therapy."

Islam said one limitation of the study is that it includes only people who have been diagnosed with HIV; it does not include those who are infected but have not been diagnosed. Therefore, she said, the true cancer burden is likely higher than the study results indicated.

Explore further: Cancer burden shifts for people with HIV/AIDS

Related Stories

Cancer burden shifts for people with HIV/AIDS

April 11, 2011
The number of cancers and the types of cancers among people living with AIDS in the U.S. have changed dramatically during the 15-year period from 1991-2005, according to an article published online April 11th in the Journal ...

Hodgkin lymphoma survivors at high risk of second cancers

March 13, 2017
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.

Study estimates global cancer cases, deaths in 2015

December 3, 2016
In 2015, there were an estimated 17.5 million cancer cases around the globe and 8.7 million deaths, according to a new report from the Global Burden of Disease Cancer Collaboration published online by JAMA Oncology.

Second, unrelated malignancies strike 1 in 12 cancer patients

July 11, 2016
(HealthDay)—A new study indicates that 8 percent of patients—or one in 12—already diagnosed with one form of cancer will develop a second unrelated malignancy. The findings were published online July 5 in Cancer.

Earlier antiretroviral therapy might reduce the burden of cancer in those with HIV

November 22, 2011
HIV-infected patients are at increased risk for cancer as a result of both their impaired immune system and lifestyle factors, such as smoking, according to researchers at Kaiser Permanente.

Recommended for you

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.